You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Sale Disclosure
Connaughton Bernadette · SEC Form 4 · Filed Jun 2, 2026
Sale
Calculated transaction value
$107.59K
Connaughton Bernadette Director
HALO
Transaction date
Jun 1, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 1 day later
HALO daily price context
Close on/before transaction
$68.14
Jun 1, 2026
First close after public filing
$69.82
Jun 3, 2026
30-day return after filing
+13.79%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,625 shares @ $66.21
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001159036-26-000072
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$107.59K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO Current | Sale | Jun 1, 2026 | $107.59K |